Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 05, 2024 01:30 ET | Source: Transgene S.A.

Transgene, NEC et BostonGene étendent leur collaboration dans le cadre de l’essai clinique de Phase I/II du vaccin individualisé TG4050

Strasbourg (France), Tokyo (Japon), Waltham (Mass. USA) – le 5 mars 2024, 7h30 - Transgene (Euronext Paris : TNG), une société de biotechnologie qui conçoit et développe des immunothérapies du cancer...
March 05, 2024 01:30 ET | Source: Transgene S.A.

Transgene, NEC, and BostonGene Expand Collaboration for Phase I/II Clinical Trial of Neoantigen Cancer Vaccine TG4050

Strasbourg (France), Tokyo (Japan) and Waltham, Mass (USA), March 5th, 2024, 7:30 am CET - Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for...